Stay updated on Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial

Sign up to get notified when there's something new on the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A banner announces that NIH websites are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    0.7%
    Check dated 2026-10-24T11:49:39.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The site footer revision identifier changes from v3.7.1 to v3.7.2, while the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-17T12:59:00.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1, with no visible change to the study record content.
    Difference
    0.1%
    Check dated 2026-10-10T13:26:41.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The Study Record Versions now shows a new latest revision (v3.7.0) and removes the previous revision (v3.6.6). This reflects a platform release update.
    Difference
    0.1%
    Check dated 2026-09-19T20:41:57.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.6.6' was added to the record history and the prior 'Revision: v3.6.5' entry was removed, reflecting an update to the platform version displayed on the page.
    Difference
    0.1%
    Check dated 2026-08-29T20:59:50.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    New revision entry v3.6.5 appears in the study's history, replacing the prior v3.6.4 entry. This update affects the record's version history rather than the study data or trial details.
    Difference
    0.1%
    Check dated 2026-08-08T20:27:49.000Z thumbnail image

Stay in the know with updates to Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page.